Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairment

L.A. Devriese; P.O. Witteveen; S. Marchetti; M. Mergui-Roelvink; L. Reyderman; J. Wanders; A. Jenner; G. Edwards; J.H. Beijnen; E.E. Voest; J.H.M. Schellens

doi:10.1007/s00280-012-1976-x

Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairment

L.A. Devriese
, P.O. Witteveen
, S. Marchetti
, M. Mergui-Roelvink
, L. Reyderman
, J. Wanders
, A. Jenner
, G. Edwards
, J.H. Beijnen
, E.E. Voest
, J.H.M. Schellens

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	823-832
Number of pages	10
Journal	Cancer Chemotherapy and Pharmacology
Volume	70
DOIs	https://doi.org/10.1007/s00280-012-1976-x
Publication status	Published - 2012

Access to Document

10.1007/s00280-012-1976-x

http://www.ncbi.nlm.nih.gov/pubmed/23010853

Cite this

@article{0ae0ae5f334f42aeb8df50cfb249c5e0,

title = "Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairment",

author = "L.A. Devriese and P.O. Witteveen and S. Marchetti and M. Mergui-Roelvink and L. Reyderman and J. Wanders and A. Jenner and G. Edwards and J.H. Beijnen and E.E. Voest and J.H.M. Schellens",

year = "2012",

doi = "10.1007/s00280-012-1976-x",

language = "English",

volume = "70",

pages = "823--832",

journal = "Cancer Chemotherapy and Pharmacology",

issn = "0344-5704",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairment

AU - Devriese, L.A.

AU - Witteveen, P.O.

AU - Marchetti, S.

AU - Mergui-Roelvink, M.

AU - Reyderman, L.

AU - Wanders, J.

AU - Jenner, A.

AU - Edwards, G.

AU - Beijnen, J.H.

AU - Voest, E.E.

AU - Schellens, J.H.M.

PY - 2012

Y1 - 2012

U2 - 10.1007/s00280-012-1976-x

DO - 10.1007/s00280-012-1976-x

M3 - Article

C2 - 23010853

SN - 0344-5704

VL - 70

SP - 823

EP - 832

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

ER -